- Home
- NIVF vs TNON Comparison
NIVF vs TNON Comparison
Compare NIVF & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIVF
- TNON
- Stock Information
- Founded
- NIVF 2011
- TNON 2012
- Country
- NIVF Hong Kong
- TNON United States
- Employees
- NIVF N/A
- TNON N/A
- Industry
- NIVF
- TNON Medical Specialities
- Sector
- NIVF
- TNON Health Care
- Exchange
- NIVF NYSE
- TNON Nasdaq
- Market Cap
- NIVF 3.9M
- TNON 3.2M
- IPO Year
- NIVF N/A
- TNON 2022
- Fundamental
- Price
- NIVF $0.71
- TNON $1.30
- Analyst Decision
- NIVF
- TNON Strong Buy
- Analyst Count
- NIVF 0
- TNON 2
- Target Price
- NIVF N/A
- TNON $16.00
- AVG Volume (30 Days)
- NIVF 357.8K
- TNON 21.4M
- Earning Date
- NIVF 01-01-0001
- TNON 05-13-2025
- Dividend Yield
- NIVF N/A
- TNON N/A
- EPS Growth
- NIVF N/A
- TNON N/A
- EPS
- NIVF N/A
- TNON N/A
- Revenue
- NIVF $5,679,218.00
- TNON $3,277,000.00
- Revenue This Year
- NIVF N/A
- TNON $118.16
- Revenue Next Year
- NIVF N/A
- TNON $7.40
- P/E Ratio
- NIVF N/A
- TNON N/A
- Revenue Growth
- NIVF N/A
- TNON 11.92
- 52 Week Low
- NIVF $0.11
- TNON $0.91
- 52 Week High
- NIVF $9.15
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- NIVF 54.67
- TNON 47.43
- Support Level
- NIVF $0.56
- TNON $2.01
- Resistance Level
- NIVF $0.77
- TNON $3.26
- Average True Range (ATR)
- NIVF 0.15
- TNON 0.51
- MACD
- NIVF -0.01
- TNON -0.01
- Stochastic Oscillator
- NIVF 75.99
- TNON 10.93
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.